IPO in HK

Pharma & Healthcare
There are 13 products.

Pharma & Healthcare

This sector provides you market resarch, import & export data, company profiles, policy and trend analysis, etc....More

  • New! Available

    A-Share Listed Pharmaceutical Companies - Profiles and Financial Data

    CRI expects that in the next few years, demand for pharmaceuticals will rise with increasing residents' income, upgrading consumption, aging population, accelerating urbanization and improving healthcare system, promoting the development of China's pharmaceutical industry.

    $ 6,500

    Add to cart View
  • Available

    A-Share Listed Medical Services Companies - Profiles and Financial Data

    According to CRI analysis, the Chinese society is aging and the medical industry is supported by the government.

    $ 500

    Add to cart View
  • Available

    A-Share Listed Biological Products Companies - Profiles and Financial Data

    In China, the market size exceeded CNY 130 billion in 2016, but its share in the pharmaceutical market was less than 10%, far below that in developed countries.

    $ 1,600

    Add to cart View
  • Available

    A-share Listed Chemical Preparation Companies - Profiles and Financial Data

    The total production value of chemical preparation in China shows a steady growing trend and increased from CNY 150.1 billion in 2006 to CNY 753.5 billion in 2016, with the CAGR of 17.5%.

    $ 1,800

    Add to cart View
  • Available

    A-share Listed Active Pharmaceutical Ingredient (API) Companies - Profiles and Financial Data

    CRI considers that China is the world's leading exporter of API and enjoys cost advantages compared with competitors. In the past decade, China's share of the global active pharmaceutical ingredient market has been increasing.

    $ 1,200

    Add to cart View
  • Available

    Research Report on China In-vitro Diagnostic Reagent Industry, 2017-2021

    In 2016, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 3, while that of developed countries reached USD 25 to USD 30.

    $ 2,200

    Add to cart View
  • Available

    China Health Examination Industry Overview, 2011-2020

    According to CRI estimation, the market value of health examination was approximately CNY 80 billion in China in 2015. It is estimated to preserve a growth rate of over 10% each in the next few years.

    $ 1,800

    Add to cart View
  • Available

    Research Report on Hemodialysis Industry in China, 2011-2020

    Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share.

    $ 2,400

    Add to cart View
  • Available

    Research Report on Hemodialysis Industry in China, 2014-2018

     The market size of Chinese hemodialysis market is expected to exceed CNY 70 billion in China by 2020 with the CAGR above 20%.

    $ 1,800

    Add to cart View
  • Available

    Research Report on Medical Industry in China, 2014-2018

    The number of medical institutions was 0.962 million by the end of November 2013, including 24,000 hospitals, 0.923 million primary medical institutions, 12,000 public medical institutions and 2,000 other institutions. The number of hospitals and public medical institutions increased by 1,564 and 247 respectively...

    $ 2,400

    Add to cart View
  • Available

    Research Report on China’s Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017

    Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion is possibly related to race and regions.

    $ 1,800

    Add to cart View
  • Research Report on China's OTC Drug Market, 2013-2017
    Available

    Research Report on China's OTC Drug Market, 2013-2017

    Since OTC drugs are mainly used by consumers without a physician's prescription in treating certain common ailments which are easy for self-diagnosis and self-treatment, the structure of their terminal market is relatively stable.…

    $ 2,400

    Add to cart View
  • Available

    Research Report on China’s Anti-Alzheimer’s Disease (AD) Drug Market, 2013-2017

    The elderly population in China will exceed 200 million by the end of 2013 and reach 221 million in 2015, accounting for 16% of the population, with a severe population aging trend.

    $ 2,800

    Add to cart View

Contact us

Our support hotline is available 24/7.

Phone:86-21-68521029

Contact our expert support team!